Showing results (341-350 of 709) with videos related to
Sort By:
Pageof 71
The American Journal of Gastroenterology|November 1, 2007
Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseasesMarcus A Wörns, Andreas Teufel, Stephan Kanzler, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapyWulf O Böcher, Marcus Schuchmann, Ralph Link, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 2, 2010
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II studyM Moehler, A Mueller, T Trarbach, et al.Oncogene|May 15, 2012
The human Lgl polarity gene, Hugl-2, induces MET and suppresses Snail tumorigenesisA Kashyap, T Zimmerman, N Ergül, et al.European Journal of Gastroenterology & Hepatology|May 1, 2013
Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspectiveMassimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infectionChristian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.Zeitschrift Fur Gastroenterologie|March 11, 2011
Acute renal failure and liver dysfunction after subcutaneous injection of 3-sn-phosphatidylcholine (Lipostabil®)-case reportJ W Rey, O Schreiner, A P Barreiros, et al.Oncotarget|September 17, 2017
Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activationNadine Gehrke, Marcus A Wörns, Amrit Mann, et al.The American Journal of Gastroenterology|January 19, 2005
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseasesJonas Mudter, Benno Weigmann, Brigitte Bartsch, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Nitric oxide promotes resistance to tumor suppression by CTLsZhanhai Su, Jürgen Kuball, Ana-Paula Barreiros, et al.Pageof 71